ICU Cases · Resuscitation
Septic shock from obstructive pyelonephritis in an older diabetic man
A full CICM Second-Part long case taking the candidate from recognition of septic shock through resuscitation, investigation, source control, and the evidence behind every key decision — built on the Sepsis-3 definitions and the Surviving Sepsis Campaign 2021 guidelines.
On this page
Study tools
Target exams
Presentation
A 68-year-old man with type 2 diabetes, hypertension, and benign prostatic hypertrophy is brought to the emergency department by his wife. Over twenty-four hours he has become febrile, confused, and anuric, with two days of dysuria and loin pain preceding a rigor this morning. On arrival he is peripherally mottled, breathing at 28/min, heart rate 124/min, blood pressure 78/46 mmHg, and oxygen saturation 92% on room air. A venous blood gas shows pH 7.22, bicarbonate 14 mmol/L, base excess −11, and lactate 6.0 mmol/L.
[4]The single most important recognition here is septic shock: he is hypotensive, his lactate is markedly raised, and he has a clear source. He meets the Sepsis-3 definition — vasopressor-dependent (or persistently) hypotension and hyperlactataemia after adequate fluid, with an in-hospital mortality that exceeds 40%.[1] Every minute from now matters.[3]
References7ShowHide
- [1]Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016.PMID 26903338
- [2]Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine, 2021.PMID 34599691
- [3]Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. New England Journal of Medicine, 2017.PMID 28528569
- [4]Asfar P, Meziani F, Hamel JF, et al. High versus Low Blood-Pressure Target in Patients with Septic Shock (SEPSISPAM). New England Journal of Medicine, 2014.PMID 24635770
- [5]Rowan KM, Angus DC, Bailey M, et al. Early, Goal-Directed Therapy for Septic Shock — A Patient-Level Meta-Analysis. New England Journal of Medicine, 2017.PMID 28320242
- [6]Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. New England Journal of Medicine, 2018.PMID 29347874
- [7]Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock (APROCCHSS). New England Journal of Medicine, 2018.PMID 29490185